Literature DB >> 12875944

Surgery in metastatic testicular cancer.

Peter Albers1, Diethild Melchior, Stefan C Müller.   

Abstract

Surgery in advanced testicular tumors is an integral part of the multimodality treatment. However, the indications for surgery in testis cancer have changed over the last 10 years. Patients with advanced seminoma only rarely will need surgery after chemotherapy whereas patients with advanced non-seminoma need to undergo the resection of residual disease in most of the cases. Surgery in metastatic disease may even be beneficial for patients with recurrent tumors, patients with persisting marker elevations during chemotherapy, or patients with late relapse of the disease. In view of late relapse, the extent and completeness of the primary resection is an important issue and, therefore, surgery should be performed in specialized centers. Most of the procedures are technically demanding and, therefore, individualized perioperative precautions are necessary to reduce morbidity of surgery. Nevertheless, in individual cases nerve-sparing techniques and laparoscopic approaches may be applicable to reduce surgery-related morbidity. This review will update the current indications and recommendations for post-chemotherapy surgery in advanced testis cancer.

Entities:  

Mesh:

Year:  2003        PMID: 12875944     DOI: 10.1016/s0302-2838(03)00252-5

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  9 in total

1.  Primary malignant bone tumors and solitary metastases of the thoracolumbar spine: results by management with total en bloc spondylectomy.

Authors:  Ingo Melcher; Alexander C Disch; Cyrus Khodadadyan-Klostermann; Stefan Tohtz; Mirko Smolny; Ulrich Stöckle; Norbert P Haas; Klaus-Dieter Schaser
Journal:  Eur Spine J       Date:  2007-01-25       Impact factor: 3.134

2.  Surgical therapy for testicular cancer metastatic to the liver.

Authors:  Mary Maluccio; Lawrence H Einhorn; Robert J Goulet
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 3.  Residual tumor resection (RTR).

Authors:  A Lusch; P Albers
Journal:  World J Urol       Date:  2016-12-21       Impact factor: 4.226

Review 4.  [Interdisciplinary cooperation in the treatment of complex patients with advanced testicular germ cell tumor].

Authors:  A Heidenreich; S Krege; M Flasshove
Journal:  Urologe A       Date:  2004-12       Impact factor: 0.639

5.  Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice.

Authors:  Axel Heidenreich; David Pfister
Journal:  Ther Adv Urol       Date:  2012-08

Review 6.  [Surgery of inferior vena cava-associated urological tumor lesions].

Authors:  M Weber; F Meyer; U B Liehr; Z Halloul
Journal:  Urologe A       Date:  2013-10       Impact factor: 0.639

7.  Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse.

Authors:  N J van As; D C Gilbert; J Money-Kyrle; D Bloomfield; S Beesley; D P Dearnaley; A Horwich; R A Huddart
Journal:  Br J Cancer       Date:  2008-06-17       Impact factor: 7.640

8.  Preservation of Ejaculatory Function After Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND) in Patients With Testicular Cancer: Template vs. Bilateral Resection.

Authors:  Andreas Hiester; Alessandro Nini; Anna Fingerhut; Robert Große Siemer; Christian Winter; Peter Albers; Achim Lusch
Journal:  Front Surg       Date:  2019-01-17

Review 9.  Major complications of post-chemotherapy retroperitoneal lymph node dissection in a contemporary cohort of patients with testicular cancer and a review of the literature.

Authors:  Christian Guido Ruf; Simon Krampe; Cord Matthies; Petra Anheuser; Tim Nestler; Jörg Simon; Hendrik Isbarn; Klaus Peter Dieckmann
Journal:  World J Surg Oncol       Date:  2020-09-24       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.